Meta Information
ID:intermittent-hypoxic-hyperoxic-training
Name:Intermittent Hypoxic-Hyperoxic Training
Schema Version:1.5
Alternate Names
- IHHT
- Hypoxia-Hyperoxia Therapy
- IHT
Active Compound
null
Intervention Type
protocol
Delivery
Route:
inhalation
Scope:
- systemic
Regulatory Status
- us:unregulated_device
- eu:unregulated_device
Indication
Focus:
healthspan
Description:
Aims to improve mitochondrial function, cellular resilience, and cardiovascular health by exposing the body to alternating periods of low and high oxygen.
Typical Protocol
- Sessions typically last 40-60 minutes and are performed 2-3 times per week.
- Each cycle involves 3-7 minutes of breathing hypoxic air (9-15% oxygen) followed by 2-5 minutes of hyperoxic air (30-36% oxygen).
- A standard course consists of 10-20 sessions over several weeks.
Expected Cost Mean
Low Cost:
5000
High Cost:
25000
Cost Type:
equipment
Description:
Cost of a home-use IHHT device; not typically covered by insurance.
Summary
IHHT involves breathing alternating cycles of low-oxygen (hypoxic) and high-oxygen (hyperoxic) air through a specialized device. This process is thought to trigger adaptive responses similar to high-altitude training, primarily by stimulating the removal of damaged mitochondria (mitophagy) and the creation of new, healthy ones (mitochondrial biogenesis). The goal is to enhance cellular energy production, improve oxygen utilization, and increase resilience to oxidative stress, thereby supporting overall healthspan.
Purpose
Enhances mitochondrial function and cellular resilience via oxygen modulation.
Card Summary
A non-invasive protocol using a device to deliver alternating low and high oxygen air, aiming to boost mitochondrial health and cellular stress resistance.
Drug Class
null
Drugs In Class
Empty Array
Impact
Score:
4.5
Justification:
Targets mitochondrial function, a key aging hallmark, but lacks large-scale human healthspan data.
Evidence
Grade:
B
Score:
5.5
Justification:
Small human trials show biomarker improvements, but large healthspan-focused RCTs are lacking.
Safety
Score:
3.5
Justification:
Generally safe but poses risks for individuals with specific cardiovascular or respiratory conditions.
Flags
- Contraindicated for individuals with severe hypertension, heart failure, epilepsy, or acute infections.
- Must be performed with proper equipment that monitors blood oxygen saturation (SpO2).
- Potential for mild side effects like headache, dizziness, or fatigue post-session.
- Quality and calibration of consumer-grade devices can vary significantly.
Verdict
A promising but developing tool for enhancing mitochondrial health and resilience.
Created
2026-05-06T16:40:55.210511Z
Ai Model
Gemini 2.5 Pro (High)